Life Saving Developments in Nucleic Acid Medicines on Innovations Television Series

Share Article

Exploring recent breakthroughs in Nano technology.

News Image
"Together with pharmaceutical companies, who are pioneers in innovative nucleic medicine, AccuRna plans to achieve its goal of saving patients and providing a higher quality of life through innovative technology..."

The highly acclaimed Innovations w/ Ed Begley Jr. television series will explore revolutionary medical breakthroughs in an upcoming episode, airing 3rd QTR 2018 on FOX Business. Check your local listings for more information.

Founded in Japan in December of 2015, AccuRna aims to promote innovative therapy in the form of Nucleic Acid Medicine utilizing its Nano DDS (Drug Delivery System) technology, supporting to provide effective treatment for refractory diseases for which there is currently no cure.

This segment will explore AccuRna's dedication to delivering a radical cure to patients suffering from refractory diseases all over the world by safely and efficiently achieving the ultimate in the therapy utilizing nucleic acid.

"Nucleic acid, such as RNA, has a mechanism for suppression/activation of protein expression. Leveraging this mechanism, nucleic acid is applicable to a medicine enabling molecule targeting, which have not been realized by conventional medicines with no genome damage," said Keiko Hattori, Chief Executive Officer for AccuRna. "This nucleic acid-based medicine, however, has technical challenges in the effectiveness at delivery to the target and stability in human body. AccuRna DDS provides simple but robust solution to those technical challenges for effective treatment of refractory diseases."

"Together with pharmaceutical companies, who are pioneers in innovative nucleic medicine, AccuRna plans to achieve its goal of saving patients and providing a higher quality of life through innovative technology," said Brett Ferrigan, producer of the Innovations series. "We look forward to bringing this vital information to our viewers."

***

About AccuRna:
AccuRna, Inc. is a Japan-based biotech startup launched in December 2015. Their mission is to contribute therapeutic innovation collaborating with any parties including pharmaceutical companies, academic organizations and research institutions, who are pioneering nucleic acid medicines. AccuRna founding/management team consists of industry veterans with extensive expertise in DDS and new medicine development. AccuRna exists to unleash previously untapped potentials on nucleic acid medicines.

For more information, visit: http://www.accurna.com

About Innovations and DMG Productions:
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.

Backed by experts in various fields, and a team dedicated to education and advancement, DMG Productions consistently produces commercial-free, educational programming on which both viewers and networks depend.

For more information visit http://www.InnovationsTelevision.com or call (866) 496-4065.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sarah McBrayer
DMG Productions
+1 8664964065 Ext: 802
Email >
Visit website